{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:34:56Z","timestamp":1783154096573,"version":"3.54.6"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02799-6","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:41:54Z","timestamp":1680608514000},"page":"770-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib"],"prefix":"10.1007","volume":"55","author":[{"given":"Artur","family":"Saldanha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eduarda","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracia","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7908-9073","authenticated-orcid":false,"given":"Fernanda A.","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Villaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"issue":"5","key":"2799_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.7861\/clinmedicine.18-5-391","volume":"18","author":"C Atkin","year":"2018","unstructured":"Atkin C, Richter A, Sapey E (2018) What is the significance of monoclonal gammopathy of undetermined significance? Clin Med (Lond) 18(5):391\u2013396. https:\/\/doi.org\/10.7861\/clinmedicine.18-5-391","journal-title":"Clin Med (Lond)"},{"issue":"13","key":"2799_CR2","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV et al (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354(13):1362\u20131369. https:\/\/doi.org\/10.1056\/NEJMoa054494","journal-title":"N Engl J Med"},{"issue":"2","key":"2799_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1182\/blood-2017-09-807560","volume":"131","author":"RS Go","year":"2018","unstructured":"Go RS, Rajkumar SV (2018) How I manage monoclonal gammopathy of undetermined significance. Blood 131(2):163\u2013173. https:\/\/doi.org\/10.1182\/blood-2017-09-807560","journal-title":"Blood"},{"issue":"8","key":"2799_CR4","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","volume":"105","author":"M Franchini","year":"2020","unstructured":"Franchini M, Mannucci PM (2020) Acquired von Willebrand syndrome: focused on hematologists. Haematologica 105(8):2032\u20132037. https:\/\/doi.org\/10.3324\/haematol.2020.255117","journal-title":"Haematologica"},{"key":"2799_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/jth.13317","volume":"14","author":"M Lavin","year":"2016","unstructured":"Lavin M, Brophy TM, Rawley O et al (2016) Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. J Thromb Haemost 14:1200\u20131205. https:\/\/doi.org\/10.1111\/jth.13317","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2799_CR6","first-page":"345","volume":"84","author":"AB Federici","year":"2000","unstructured":"Federici AB, Rand JH, Bucciarelli P et al (2000) Acquired von Willebrand syndrome: data from an International registry. Thromb Haemost 84(2):345\u2013349","journal-title":"Thromb Haemost"},{"issue":"2","key":"2799_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0033-1334867","volume":"39","author":"AB Federici","year":"2013","unstructured":"Federici AB, Budde U, Castaman G, Rand JH, Tiede A (2013) Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost 39(2):191\u2013201. https:\/\/doi.org\/10.1055\/s-0033-1334867","journal-title":"Semin Thromb Hemost"},{"key":"2799_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rth2.12481","volume":"00","author":"MY Abou-Ismail","year":"2021","unstructured":"Abou-Ismail MY, Rodgers GM, Bray PF, Lim MY (2021) Acquired von Willebrand syndrome in monoclonal gammopathy \u2013 a scoping review on hemostatic management. Res Pract Thromb Haemost 00:1\u201310. https:\/\/doi.org\/10.1002\/rth2.12481","journal-title":"Res Pract Thromb Haemost"},{"key":"2799_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/s1297-319x(01)00343-8","volume":"69","author":"V Lamboley","year":"2002","unstructured":"Lamboley V, Zabraniecki L, Sie P et al (2002) Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand\u2019s syndrome. Seven new cases with a literature review. Joint Bone Spine 69:62\u201367. https:\/\/doi.org\/10.1016\/s1297-319x(01)00343-8","journal-title":"Joint Bone Spine"},{"issue":"8","key":"2799_CR10","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","volume":"92","author":"AB Federici","year":"1998","unstructured":"Federici AB, Stabile F, Castaman G et al (1998) Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood 92(8):2707\u20132711","journal-title":"Blood"},{"issue":"14","key":"2799_CR11","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1182\/bloodadvances.2021004843","volume":"5","author":"KE Dane","year":"2021","unstructured":"Dane KE, Lindsley JP, Kickler T (2021) Continuous-infusion von willebrand factor concentrate is effective for the management of acquired von Willebrand disease. Blood Adv 5(14):2813\u20132816. https:\/\/doi.org\/10.1182\/bloodadvances.2021004843","journal-title":"Blood Adv"},{"key":"2799_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MD.0b013e3182397166","volume":"90","author":"S Voisin","year":"2011","unstructured":"Voisin S, Hamidou M, Lefrancois A et al (2011) Acquired von Willebrand syndrome associated with monoclonal gammopathy. A single-center study of 36 patients. Medicine 90:404\u2013411. https:\/\/doi.org\/10.1097\/MD.0b013e3182397166","journal-title":"Medicine"},{"issue":"4","key":"2799_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/hae.12701","volume":"21","author":"ET Engelen","year":"2015","unstructured":"Engelen ET, Galen KPM, Schutgens (2015) Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature. Haemophilia 21(4):419\u2013429. https:\/\/doi.org\/10.1111\/hae.12701","journal-title":"Haemophilia"},{"key":"2799_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ajh.21692","volume":"85","author":"M Ojeda-Uribe","year":"2010","unstructured":"Ojeda-Uribe M, Caron C, Itzhar-Baikian N et al (2010) Bortezomib effectiveness in one patient with acquired von Willebrand syndrome associated to monoclonal gammopathy of undetermined significance. Am J Hematol 85:396. https:\/\/doi.org\/10.1002\/ajh.21692","journal-title":"Am J Hematol"},{"issue":"6","key":"2799_CR15","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1111\/hae.13077","volume":"22","author":"S Katagiri","year":"2016","unstructured":"Katagiri S, Akahane D, Amano K et al (2016) Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy. Haemophilia 22(6):e557\u2013e559. https:\/\/doi.org\/10.1111\/hae.13077","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02799-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T03:59:38Z","timestamp":1682740778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02799-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2799"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02799-6","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"15 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the individual described in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}